Life sciences
Canadian life insurer and asset manager Manulife has boosted its presence in the healthy ageing sector with the launch of a US$350m Longevity Institute. Valued at US$60bn, Manulife has been active in the longevity space for some time and says the new institute will see it fund ‘innovative research, and key industry collaborations’. Manulife’s chief [...]
Scotland has set out a life sciences strategy aimed at growing the sector to £25bn by 2035. The Scottish Government’s refreshed Life Sciences Strategy focuses on infrastructure and skills, and brings in technologies such as artificial intelligence. An initial £1m will support delivery. Business minister Richard Lochhead, who launched the strategy at Dundee [...]
By McDermott Will & Schulte European life sciences businesses have been closely tracking geopolitics and global policy changes over the past 12 months, particularly as the new administration in the United States heightens its focus on drug pricing. Against this backdrop, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will [...]
The British Business Bank has committed €30m to Sofinnova Partners’ €650m life sciences fund, Sofinnova Capital XI. The fund will support early-stage biopharmaceutical and medical technology companies developing treatments for unmet medical needs, with initial and follow-on investments as firms grow. The commitment supports the UK’s Life Sciences Sector Plan and builds on the bank’s [...]
A leading cancer expert is challenging widespread misconceptions about radiotherapy which she says is marginalised by healthcare systems despite contributing to 40 per cent of cancer cures. Professor Pat Price, visiting professor at Imperial College London and chair of both Radiotherapy UK and the Global Coalition for Radiotherapy (GCR), has authored a comprehensive report highlighting [...]
By Sergey Jakimov and Artem Trotsyuk, managing and operating partners, LongeVC Artificial intelligence is rapidly rewriting medicine – from clinics to labs – and scientists, startups, regulators, and investors are shaping that shift together. The global healthcare AI market is projected to soar from just over $1 billion in 2016 to more than $28 billion [...]
Thousands of Scots in deprived areas will be offered free weight-loss injections in a government-funded trial launching next year. The UK government has provided an initial £650,000 for up to 5,000 participants in the Scotland CardioMetabolic Impact Study (SCoMIS). The multi-million pound study will be led by Glasgow University in partnership with the Universities of [...]
By Prof Mick Thacker, Dr Kate Ryan and Leslie Pan Pain, particularly musculoskeletal (MSK) pain, is both pervasive and complex. Globally, approximately 1.71 billion people suffer from MSK conditions, which account for the leading cause of disability worldwide, with lower back pain being the single biggest contributor across 160 countries [1]. In the UK alone, [...]
Britain will struggle to be a life sciences superpower without reforming drug pricing, GSK’s outgoing chief executive has warned. Emma Walmsley said she was “hopeful and ambitious” that the standoff between the pharmaceutical industry and government could be resolved, as ministers draw up proposals to increase NHS spending on new medicines by up to 25 [...]
Prostate cancer screening could reduce deaths by 13 per cent, research has revealed, prompting UK experts to assess whether to introduce a national screening programme. Cancer screening specialists are reviewing the evidence, with a decision expected before the end of the year on whether routine prostate testing should be introduced across the UK. A new [...]
